Van Epps, 2000 - Google Patents
CD34 Cell Culture: Clinical Needs and ApplicationsVan Epps, 2000
- Document ID
- 16618503211582377130
- Author
- Van Epps D
- Publication year
- Publication venue
- Hematopoietic Stem Cell Transplantation
External Links
Snippet
I. INTRODUCTION Stem cell transplantation has undergone a dramatic change over the past few years both in the numbers of transplants and in the way that these transplants are being done. Stem cell transplants are increasing at a rate of more than 20% per year with …
- 102100016492 CD34 0 title abstract 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yañez et al. | Adipose tissue‐derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft‐versus‐host disease | |
| Bader et al. | Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells | |
| Little | Repair of potentially-lethal radiation damage in mammalian cells: enhancement by conditioned medium from stationary cultures | |
| WO2003066072A3 (en) | Cell therapy using immunoregulatory t-cells | |
| He et al. | The effects and mechanisms of a novel 2-aminosteroid on murine WEHI-3B leukemia cells in vitro and in vivo | |
| Cohrs et al. | Effect of vitamin E succinate and a cAMP-Stimulating agent on the expression of c-myc, N-myc and H-ras in murine neuroblastoma cells | |
| Malone et al. | Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer | |
| Bichel et al. | Hyperthermic effect on exponential and plateau ascites tumor cells in vitro dependent on environmental pH | |
| KR20170089924A (en) | Stem cell material and method of manufacturing | |
| Baronciani et al. | Hematopoietic cell transplantation in thalassemia and sickle cell disease: report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry: 2000-2017 | |
| Najima et al. | Mesenchymal stem cells: the first approved stem cell drug in Japan | |
| Van Epps | CD34 Cell Culture: Clinical Needs and Applications | |
| JPH07102131B2 (en) | Method for enhancing cytotoxicity of human lymphocytes against cancer cells | |
| Rafat et al. | Bone marrow CD34 positive cells may be suitable for collection after death | |
| Tian et al. | Karyotyping, immunophenotyping, and apoptosis analyses on human hematopoietic precursor cells derived from umbilical cord blood following long-term ex vivo expansion | |
| Imai et al. | Interleukin-2 Gene Transduction in Human Natural Killer Cells Augments Their Survival and Anti-Leukemic Capacity | |
| Imrie et al. | Autologous bone marrow transplantation for acute myeloid leukemia | |
| Vielkind et al. | DNA-mediated transformation in the platyfish-swordtail melanoma system | |
| Zaccaria et al. | Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia | |
| Huang et al. | Expression of bcl-2 in human ocular surface epithelia | |
| Poiani et al. | The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT | |
| Nasri et al. | A Universal CRISPR/Cas9n-Mediated Genome Editing Approach for ELANE-Related Severe Congenital Neutropenia | |
| Kessinger | Blood Stem Cell Versus Bone Marrow Transplantation: A Critical Appraisal | |
| Battipaglia et al. | Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Siblings Versus Unmanipulated Haploidentical Donors in Relapsing or Refractory Acute Myeloid Leukemia: A Retrospective Study from the ALWP of the EBMT | |
| Henao et al. | GENETIC STABILITY OF UMBILICAL CORD STEM CELLS |